Product Name

  • Name

    Saquinavir

  • EINECS 1806241-263-5
  • CAS No. 127779-20-8
  • Article Data6
  • CAS DataBase
  • Density 1.211 g/cm3
  • Solubility 35.8mg/L(25 oC)
  • Melting Point 91.5oC
  • Formula C38H50N6O5
  • Boiling Point 1015 °C at 760 mmHg
  • Molecular Weight 670.852
  • Flash Point 567.7 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 127779-20-8 (Saquinavir)
  • Hazard Symbols
  • Synonyms Butanediamide,N1-[3-[3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-,[3S-[2[1R*(R*),2S*],3a,4ab,8ab]]-;(S)-N-[(aS)-a-[(1R)-2-[(3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl]-1-hydroxyethyl]phenethyl]-2-quinaldamidosuccinamide;Fortovase;Ro 31-8959/000;Sch 52852;
  • PSA 166.75000
  • LogP 4.90330

Saquinavir History

  Saquinavir (CAS No.127779-20-8) was the first protease inhibitor (and sixth antiretroviral) ,which was approved on December 6, 1995 by the Food and Drug Administration (FDA) .
  It was approved again on Nov 7, 1997 as Fortovase, a soft gel capsule reformulated for improved bioavailability.
  Roche announced in May 2005 that, owing to reduction in demand, Fortovase would cease being marketed early in 2006 in favour of Invirase boosted with ritonavir.

Saquinavir Specification

The Saquinavir, with the CAS registry number 127779-20-8, is also known as N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-butanediamide. It belongs to the product categories of Active Pharmaceutical Ingredients; Saquinavir. This chemical's molecular formula is C38H50N6O5 and molecular weight is 670.84. What's more, its IUPAC name is called (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide. The production is an antiretroviral drug used in HIV therapy. In addition, it falls in the protease inhibitor class. The most frequent adverse events with saquinavir in either formulation are mild gastrointestinal symptoms, including diarrhea, nausea, loose stools & abdominal discomfort. This chemical can be prepared by N-Phthalic acyl-(S)-styrene-acrylic ammonia carbonyl chlorides with 1,1,2-Tris(trimethylsilyloxy)ethene. This reaction needs reagent HCl and solvents ethyl acetate, hexane.

Physical properties about Saquinavir are: (1)ACD/LogP: 4.03; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): 1.96; (4)ACD/LogD (pH 7.4): 3.61; (5)ACD/BCF (pH 5.5): 5.79; (6)ACD/BCF (pH 7.4): 260.25; (7)ACD/KOC (pH 5.5): 31.52; (8)ACD/KOC (pH 7.4): 1417.08; (9)#H bond acceptors: 11; (10)#H bond donors: 6; (11)#Freely Rotating Bonds: 14; (12)Polar Surface Area: 106.6 Å2; (13)Index of Refraction: 1.598; (14)Molar Refractivity: 189.12 cm3; (15)Molar Volume: 553.8 cm3; (16)Surface Tension: 54.2 dyne/cm; (17)Density: 1.211 g/cm3; (18)Flash Point: 567.7 °C; (19)Enthalpy of Vaporization: 155.26 kJ/mol; (20)Boiling Point: 1015 °C at 760 mmHg; (21)Vapour Pressure: 0 mmHg at 25 °C.

You can still convert the following datas into molecular structure:
(1) SMILES: O=C(N)C[C@H](NC(=O)c1nc2c(cc1)cccc2)C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN5[C@H](C(=O)NC(C)(C)C)C[C@@H]4CCCC[C@@H]4C5
(2) InChI: InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1
(3) InChIKey: QWAXKHKRTORLEM-UGJKXSETSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View